# Influence of Polyglucosamine L112 on Serum Surrogate Markers of Cholesterol Absorption

> **NCT05038436** · NA · COMPLETED · sponsor: **Certmedica International GmbH** · enrollment: 30 (actual)

## Conditions studied

- Cholesterol Lowering

## Interventions

- **DEVICE:** Polyglucosamine L112

## Key facts

- **NCT ID:** NCT05038436
- **Lead sponsor:** Certmedica International GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-16
- **Primary completion:** 2022-06-21
- **Final completion:** 2022-06-21
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05038436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05038436, "Influence of Polyglucosamine L112 on Serum Surrogate Markers of Cholesterol Absorption". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05038436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*